Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Erik A. Imel

ResearcherPublications, citations & collaboration network

Erik A. Imel is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 226 works, 8,271 citations, an h-index of 45 and an i10-index of 87.

226
Works
8,271
Citations
45
h-index
87
i10-index

How has Erik A. Imel's publication output changed over time?

ScholarIQpublication output · 2006–2022

Output grew0% over the shown period — from 1 works in 2006 to 1 in 2022.

1
1
1
2
1
2
1
1
1
200620072010201120142018201920202022

What are the most-cited papers on Erik A. Imel?

ScholarIQmost cited works
A clinician's guide to X-linked hypophosphatemia
Thomas O. Carpenter, Erik A. Imel, Ingrid A. Holm, Suzanne M. Jan de Beur, Karl Insogna
Journal of Bone and Mineral Research. 2011616 CitationsOPEN ACCESS
Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects
Y. Yamazaki, Akihiro Imura, Itaru Urakawa, Takashi Shimada, Junko Murakami, Yukiko Aono, Hisashi Hasegawa, Takeyoshi Yamashita, Kimihiko Nakatani, Yoshihiko Saito, Nozomi Okamoto, Norio Kurumatani, Noriyuki Namba, Taichi Kitaoka, Keiichi Ozono, Tomoyuki Sakai, Hiroshi Hataya, Shoji Ichikawa, Erik A. Imel, Michael J. Econs, Y Nabeshima
Biochemical and Biophysical Research Communications. 2010500 CitationsOPEN ACCESS
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Shoji Ichikawa, Erik A. Imel, Mary L. Kreiter, Xijie Yu, Donald S. Mackenzie, Andrea H. Sorenson, Regina Goetz, Moosa Mohammadi, Kenneth E. White, Michael J. Econs
S114430552. 2007484 CitationsOPEN ACCESS
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter, Michael P. Whyte, Erik A. Imel, Annemieke M. Boot, Wolfgang Högler, Agnès Linglart, Raja Padidela, William van’t Hoff, Meng Mao, Chao-Yin Chen, Alison Skrinar, Emil Kakkis, Javier San Martín, Anthony A. Portale
New England Journal of Medicine. 2018478 CitationsOPEN ACCESS
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
Erik A. Imel, Francis H. Glorieux, Michael P. Whyte, Craig F. Munns, Leanne M. Ward, Ola Nilsson, Jill H. Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S. Gottesman, Andrew Biggin, Farzana Perwad, Meng Mao, Chao-Yin Chen, Alison Skrinar, Javier San Martín, Anthony A. Portale
The Lancet. 2019373 CitationsOPEN ACCESS

Related on ScholarIQ

Indiana University Health
Institution
A clinician's guide to X-linked hypophosphatemia
Paper
Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects
Paper
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Paper
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Paper
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
Paper
470M+ articles · free account